Screening for elevated albuminuria and subsequently hypertension identifies subjects in which treatment may be warranted to prevent renal function decline

Autor: Stephan J. L. Bakker, Sipke T. Visser, Paul E. de Jong, Chris H. L. Thio, Akin Ozyilmaz, Ron T. Gansevoort
Přispěvatelé: Groningen Institute for Organ Transplantation (GIOT), Lifestyle Medicine (LM), Groningen Kidney Center (GKC), PharmacoTherapy, -Epidemiology and -Economics, Cardiovascular Centre (CVC)
Jazyk: angličtina
Rok vydání: 2017
Předmět:
Male
030232 urology & nephrology
detection
Blood Pressure
PROGRESSION
030204 cardiovascular system & hematology
GLOMERULAR-FILTRATION-RATE
DISEASE
0302 clinical medicine
Risk Factors
Prevalence
Prospective Studies
Renal Insufficiency
Prospective cohort study
Morning
GENERAL-POPULATION
ACE-INHIBITION
RISK
education.field_of_study
Middle Aged
Nephrology
Disease Progression
Female
medicine.symptom
Cohort study
Glomerular Filtration Rate
Adult
medicine.medical_specialty
hypertension
Population
Urology
Renal function
Sensitivity and Specificity
albuminuria
DIETARY-PROTEIN RESTRICTION
03 medical and health sciences
Internal medicine
medicine
Humans
STRATEGY
education
CARDIOVASCULAR EVENTS
METAANALYSIS
Aged
Transplantation
kidney function decline
business.industry
screening
Confidence interval
Endocrinology
Blood pressure
Albuminuria
business
Zdroj: Nephrology, Dialysis, Transplantation, 32(2), 200-208. Oxford University Press
ISSN: 1460-2385
0931-0509
Popis: Background. We investigated whether initial population screening for elevated albuminuria with subsequent screening for hypertension in case albuminuria is elevated may be of help to identify subjects at risk for accelerated decline in kidney function.Methods. We included subjects who participate in the PREVEND observational, general population-based cohort study and had two or more glomerular filtration rate (eGFR) measurements available during follow-up. Elevated albuminuria was defined as an albumin concentration >= 20 mg/L in a first morning urine sample confirmed by an albumin excretion >= 30mg/day in two 24-h urines. Hypertension was defined as systolic blood pressure >= 140mmHg, diastolic blood pressure >= 90mmHg or use of blood pressure-lowering drugs. eGFR was estimated with the CKD-EPI creatinine-cystatin C equation.Results. Overall, 6471 subjects were included with a median of 4 [95% confidence interval (CI) 2-5] eGFR measurements during a follow-up of 11.3 (95% CI 4.0-13.7) years. Decline in eGFR was greater in the subgroups with elevated albuminuria. This held true, not only in subjects with known hypertension (-1.84+/-2.27 versus -1.16+/-1.45mL/min/1.73m(2) per year, P= 55 years of age andmale subjects. In addition, subjects with elevated albuminuria had higher blood pressure than subjects with normoalbuminuria, and in subjects with elevated albuminuria as yet undiagnosed hypertension was twice as prevalent as diagnosed hypertension.Conclusions. Initial screening for elevated albuminuria followed by screening for hypertension may help to detect subjects with increased risk for a steeper decline in kidney function.
Databáze: OpenAIRE